Tag: James Lin
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
Firms advise on GPU developer Biren’s HKD5.6bn Hong Kong IPO
Chinese GPU developer Biren Technology listed on HKEX’s main board on 2 January, first of its kind to go public
Firms help brew bubble tea chain Chagee’s USD411m IPO
Chagee raises USD411m in Nasdaq debut, marking the second-largest Chinese IPO in the US in three years after Zeekr
Firms act on China tech giant Baidu’s RMB10bn offshore bonds
Skadden, Han Kun, Jingtian & Gongcheng, and Davis Polk advised Baidu on its USD1.48bn offshore bond issuance
Quintet steers Pony AI’s USD413m Nasdaq IPO
Pony AI raised USD 413 million in its Nasdaq IPO, marking the third-largest Chinese debut in the US
Davis Polk, Appleby and Latham & Watkins act on USD23bn SPAC merger
Davis Polk, Appleby and Latham & Watkins advised on a proposed special purpose acquisition company (SPAC) merger involving Vietnamese electric vehicle manufacturer VinFast at an equity value of USD23 billion
